Cleavage efficient 2A peptides for high level monoclonal antibody expression in CHO cells

Linking the heavy chain (HC) and light chain (LC) genes required for monoclonal antibodies (mAb) production on a single cassette using 2A peptides allows control of LC and HC ratio and reduces non-expressing cells. Four 2A peptides derived from the foot-and-mouth disease virus (F2A), equine rhinitis A virus (E2A), porcine teschovirus-1 (P2A) and Thosea asigna virus (T2A), respectively, were compared for expression of 3 biosimilar IgG1 mAbs in Chinese hamster ovary (CHO) cell lines. HC and LC were linked by different 2A peptides both in the absence and presence of GSG linkers. Insertion of a furin recognition site upstream of 2A allowed removal of 2A residues that would otherwise be attached to the HC. Different 2A peptides exhibited different cleavage efficiencies that correlated to the mAb expression level. The relative cleavage efficiency of each 2A peptide remains similar for expression of different IgG1 mAbs in different CHO cells. While complete cleavage was not observed for any of the 2A peptides, GSG linkers did enhance the cleavage efficiency and thus the mAb expression level. T2A with the GSG linker (GT2A) exhibited the highest cleavage efficiency and mAb expression level. Stably amplified CHO DG44 pools generated using GT2A had titers 357, 416 and 600 mg/L for the 3 mAbs in shake flask batch cultures. Incomplete cleavage likely resulted in incorrectly processed mAb species and aggregates, which were removed with a chromatin-directed clarification method and protein A purification. The vector and methods presented provide an easy process beneficial for both mAb development and manufacturing.

[1]  M. Sachs,et al.  Site-Specific Release of Nascent Chains from Ribosomes at a Sense Codon , 2008, Molecular and Cellular Biology.

[2]  M. Yap,et al.  Mutated polyadenylation signals for controlling expression levels of multiple genes in mammalian cells , 2009, Biotechnology and bioengineering.

[3]  J. Asenjo,et al.  Kinetic model of BiP- and PDI-mediated protein folding and assembly. , 2002, Journal of theoretical biology.

[4]  P. Gagnon,et al.  Characterization and removal of aggregates formed by nonspecific interaction of IgM monoclonal antibodies with chromatin catabolites during cell culture production. , 2013, Journal of chromatography. A.

[5]  A. Racher,et al.  On the Optimal Ratio of Heavy to Light Chain Genes for Efficient Recombinant Antibody Production by CHO Cells , 2008, Biotechnology progress.

[6]  Andrew J Racher,et al.  Cell line‐specific control of recombinant monoclonal antibody production by CHO cells , 2010, Biotechnology and bioengineering.

[7]  Rui Nian,et al.  Nonspecific interactions of chromatin with immunoglobulin G and protein A, and their impact on purification performance. , 2014, Journal of chromatography. A.

[8]  Jeremy D. Brown,et al.  Inhibition of 2A-mediated ‘cleavage’ of certain artificial polyproteins bearing N-terminal signal sequences , 2010, Biotechnology journal.

[9]  S. J. Wilkinson,et al.  Model‐directed engineering of “difficult‐to‐express” monoclonal antibody production by Chinese hamster ovary cells , 2014, Biotechnology and bioengineering.

[10]  J. Allison,et al.  Local secretion of anti-CTLA-4 enhances the therapeutic efficacy of a cancer immunotherapy with reduced evidence of systemic autoimmunity , 2008, Cancer Immunology, Immunotherapy.

[11]  M. Sachs,et al.  Dissection of a co-translational nascent chain separation event. , 2008, Biochemical Society transactions.

[12]  H. Knopf,et al.  Combination of the 2A/furin technology with an animal component free cell line development platform process , 2010, Applied Microbiology and Biotechnology.

[13]  K. Jooss,et al.  An antibody delivery system for regulated expression of therapeutic levels of monoclonal antibodies in vivo. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[14]  Yeping Tan,et al.  Coexpression of double or triple copies of the rabies virus glycoprotein gene using a 'self-cleaving' 2A peptide-based replication-defective human adenovirus serotype 5 vector. , 2010, Biologicals : journal of the International Association of Biological Standardization.

[15]  M. Bardor,et al.  Control of IgG LC:HC ratio in stably transfected CHO cells and study of the impact on expression, aggregation, glycosylation and conformational stability. , 2013, Journal of biotechnology.

[16]  H. Hauser,et al.  Composition and arrangement of genes define the strength of IRES-driven translation in bicistronic mRNAs. , 2001, Nucleic acids research.

[17]  E. ten Dam,et al.  The 'cleavage' activities of foot-and-mouth disease virus 2A site-directed mutants and naturally occurring '2A-like' sequences. , 2001, The Journal of general virology.

[18]  H. Park,et al.  High Cleavage Efficiency of a 2A Peptide Derived from Porcine Teschovirus-1 in Human Cell Lines, Zebrafish and Mice , 2011, PloS one.

[19]  J. Reichert,et al.  Development trends for human monoclonal antibody therapeutics , 2010, Nature Reviews Drug Discovery.

[20]  Andrew J Racher,et al.  Antibody production. , 2006, Advanced drug delivery reviews.

[21]  Daniel I. C. Wang,et al.  Vector fragmentation: Characterizing vector integrity in transfected clones by Southern blotting , 2010, Biotechnology progress.

[22]  Joni Tsukuda,et al.  A clone screening method using mRNA levels to determine specific productivity and product quality for monoclonal antibodies , 2009, Biotechnology and bioengineering.

[23]  D. Schübeler,et al.  Stabilized, long-term expression of heterodimeric proteins from tricistronic mRNA. , 2000, Gene.

[24]  Y. Voziyanov,et al.  Flp and Cre expressed from Flp–2A–Cre and Flp–IRES–Cre transcription units mediate the highest level of dual recombinase-mediated cassette exchange , 2012, Nucleic acids research.

[25]  M. Bardor,et al.  IRES-mediated Tricistronic vectors for enhancing generation of high monoclonal antibody expressing CHO cell lines. , 2012, Journal of biotechnology.

[26]  Claire Halpin,et al.  E unum pluribus: multiple proteins from a self-processing polyprotein. , 2006, Trends in biotechnology.

[27]  I. Lindberg,et al.  A study of human furin specificity using synthetic peptides derived from natural substrates, and effects of potassium ions. , 2009, Archives of biochemistry and biophysics.

[28]  R. Siezen,et al.  Furin is a subtilisin-like proprotein processing enzyme in higher eukaryotes , 1990, Molecular Biology Reports.

[29]  S. Rosenberg,et al.  Development of optimal bicistronic lentiviral vectors facilitates high-level TCR gene expression and robust tumor cell recognition , 2008, Gene Therapy.

[30]  Smaroula Dilioglou,et al.  Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide–based retroviral vector , 2004, Nature Biotechnology.

[31]  M. Ryan,et al.  Protein Coexpression Using FMDV 2A: Effect of “Linker” Residues , 2013, BioMed research international.

[32]  K. Jooss,et al.  Stable antibody expression at therapeutic levels using the 2A peptide , 2005, Nature Biotechnology.

[33]  S. Dübel,et al.  Analysis of IgG heavy chain to light chain ratio with mutant Encephalomyocarditis virus internal ribosome entry site. , 2007, Protein engineering, design & selection : PEDS.

[34]  Niki S. C. Wong,et al.  A study of monoclonal antibody‐producing CHO cell lines: What makes a stable high producer? , 2009, Biotechnology and bioengineering.

[35]  Juan Shi,et al.  2A peptide-based, lentivirus-mediated anti-death receptor 5 chimeric antibody expression prevents tumor growth in nude mice. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[36]  S. Dübel,et al.  A comparative study of different vector designs for the mammalian expression of recombinant IgG antibodies. , 2007, Journal of immunological methods.

[37]  M. Ryan,et al.  Optimisation of the foot-and-mouth disease virus 2A co-expression system for biomedical applications , 2013, BMC Biotechnology.

[38]  A. Dickson,et al.  Molecular analysis of successful cell line selection in transfected GS‐NS0 myeloma cells , 2007, Biotechnology and bioengineering.

[39]  Steven C L Ho,et al.  Generation of monoclonal antibody-producing mammalian cell lines , 2013 .

[40]  Zhiwei Song,et al.  An Internal Ribosome Entry Site (IRES) Mutant Library for Tuning Expression Level of Multiple Genes in Mammalian Cells , 2013, PloS one.

[41]  Helena Escuin-Ordinas,et al.  Newcastle University E-prints Citation for Item: Publisher's Copyright Statement: 2a Peptides Provide Distinct Solutions to Driving Stop-carry on Translational Recoding , 2022 .

[42]  D. James,et al.  Predicting the expression of recombinant monoclonal antibodies in Chinese hamster ovary cells based on sequence features of the CDR3 domain , 2014, Biotechnology progress.

[43]  M. Bardor,et al.  Comparison of Internal Ribosome Entry Site (IRES) and Furin-2A (F2A) for Monoclonal Antibody Expression Level and Quality in CHO Cells , 2013, PloS one.

[44]  Andrew J Racher,et al.  Impact of gene vector design on the control of recombinant monoclonal antibody production by chinese hamster ovary cells , 2011, Biotechnology progress.